SCHEMBL4618233

SCHEMBL4618233

CC(C)(CO)NS(=O)(=O)c1cc(S(=O)(=O)c2ccccc2)ccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
SLC12A2 P55011 1/20 0.48
SLC12A5 Q9H2X9 1/20 0.48
GLA P06280 1/20 0.47
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
POLB P06746 1/20 0.44
SFRP1 Q8N474 2/20 0.43
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
SLC16A1 P53985 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
HSD11B1 P28845 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616215 0.86 SFRP1 (0.58) LMNAALDH1A1KDM4EL3MBTL1POLB
SCHEMBL4636847 0.83 LMNA (0.47) LMNASLC12A2SLC12A5GLAALDH1A1
SCHEMBL4617971 0.80 LMNA (0.45) LMNASLC12A2SLC12A5GLAALDH1A1
SCHEMBL4616119 0.79 LMNA (0.57) LMNASLC12A2SLC12A5GLAALDH1A1
SCHEMBL4617963 0.79 LMNA (0.47) LMNASLC12A2SLC12A5GLAALDH1A1
SCHEMBL4618473 0.78 LMNA (0.49) LMNASLC12A2SLC12A5GLAALDH1A1
SCHEMBL1479993 0.77 ALDH1A1 (0.56) GLAALDH1A1KDM4EL3MBTL1MAPT
SCHEMBL4617968 0.76 LMNA (0.53) LMNASLC12A2SLC12A5GLAALDH1A1
SCHEMBL4618655 0.75 LMNA (0.56) LMNASLC12A2SLC12A5GLAALDH1A1
SCHEMBL4618477 0.75 LMNA (0.52) LMNASLC12A2SLC12A5GLAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 LMNA 4608/4885SLC12A2 1974/4885SLC12A5 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.